AU2151897A - Bis-heterocyclic derivatives - Google Patents

Bis-heterocyclic derivatives

Info

Publication number
AU2151897A
AU2151897A AU21518/97A AU2151897A AU2151897A AU 2151897 A AU2151897 A AU 2151897A AU 21518/97 A AU21518/97 A AU 21518/97A AU 2151897 A AU2151897 A AU 2151897A AU 2151897 A AU2151897 A AU 2151897A
Authority
AU
Australia
Prior art keywords
bis
heterocyclic derivatives
heterocyclic
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21518/97A
Inventor
Kurt Vesterager GOTHELF
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aarhus Universitet
Original Assignee
Aarhus Universitet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aarhus Universitet filed Critical Aarhus Universitet
Publication of AU2151897A publication Critical patent/AU2151897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU21518/97A 1996-03-15 1997-03-14 Bis-heterocyclic derivatives Abandoned AU2151897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK30496 1996-03-15
DK304/96 1996-03-15
PCT/DK1997/000112 WO1997034881A1 (en) 1996-03-15 1997-03-14 Bis-heterocyclic derivatives

Publications (1)

Publication Number Publication Date
AU2151897A true AU2151897A (en) 1997-10-10

Family

ID=8092049

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21518/97A Abandoned AU2151897A (en) 1996-03-15 1997-03-14 Bis-heterocyclic derivatives

Country Status (2)

Country Link
AU (1) AU2151897A (en)
WO (1) WO1997034881A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1102755B1 (en) * 1998-08-07 2006-01-04 Chiron Corporation Substituted isoxazole derivatives as estrogen receptor modulators
BRPI0612028A2 (en) * 2005-06-08 2010-10-13 Novartis Ag polycyclic oxadiazoles or isodiazoles and their use as s1p receptor ligands
US8927551B2 (en) 2009-05-18 2015-01-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US9149465B2 (en) 2009-05-18 2015-10-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US8765735B2 (en) 2009-05-18 2014-07-01 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase

Also Published As

Publication number Publication date
WO1997034881A1 (en) 1997-09-25

Similar Documents

Publication Publication Date Title
AU2647597A (en) Oxindole derivatives
AU4620397A (en) Piperazine derivatives
AU1151099A (en) Azaoxindole derivatives
AU1825899A (en) Dota-biotin derivatives
AU1735497A (en) Sulfonylureidopyrazole derivatives
AU1594697A (en) New substituted 19-nor-pregnane derivatives
AU4400597A (en) Indole derivatives
AU3867997A (en) Chromene-3-carboxylate derivatives
AU7738098A (en) Novel tetrahydrobenzindolone derivatives
AU2956097A (en) Alkylaminobenzothiazole and -benzoxazole derivatives
AUPO284396A0 (en) Benzodiazepine derivatives
EP1008579A3 (en) Cyclopentenebutanol derivatives
AU2961097A (en) Substituted pyrazolylpyrazole derivatives
AU4962097A (en) 2-methoxyphenylpiperazine derivatives
AU1793197A (en) Pyrazole-4-yl-hetaroyl derivatives
AU1174199A (en) Biphenylamidine derivatives
AU3091397A (en) Novel pyrrole derivatives
AU3685097A (en) N-benzylazolium derivatives
AU1671597A (en) Indole derivatives
AU1600297A (en) Aryl derivatives
AU6370196A (en) Indole derivatives
AU2151897A (en) Bis-heterocyclic derivatives
AU4355296A (en) Indole derivatives
AU4224196A (en) Substituted indole derivatives
AU1562199A (en) Amino-benzothiazole derivatives